EP Patent

EP3008471B1 — Methods for determining total body skeletal muscle mass

Assigned to GlaxoSmithKline Intellectual Property No 2 Ltd · Expires 2017-03-15 · 9y expired

What this patent protects

Patent listed against Renacidin.

Drugs covered by this patent

Patent Metadata

Patent number
EP3008471B1
Jurisdiction
EP
Classification
—
Expires
2017-03-15
Drug substance claim
No
Drug product claim
No
Assignee
GlaxoSmithKline Intellectual Property No 2 Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.